Posts

Optica Publishing Group launches new Gold Open Access J...

WASHINGTON—Optica Publishing Group today published the first issue of its newest...

Engineers develop an efficient process to make fuel fro...

CAMBRIDGE, Mass. — The search is on worldwide to find ways to extract carbon dio...

UBC Okanagan researchers work to be guardians of the city

As technology continues to advance, the likelihood of malevolent attacks and sub...

Research Brief: Study uncovers hundred-year lifespans f...

A recent study found some of the oldest animals in the world living in a place y...

Soy expansion in Brazil linked to increase in childhood...

URBANA, Ill. – Over the past decades, Brazil has become the world’s leading soyb...

NYU Abu Dhabi researchers reveal how common desert shru...

Abu Dhabi, UAE, October 2023: A team of scientists, led by Post-Doctoral Associa...

A microscope that can monitor the development of the heart

The ability to dynamically track the movement of cells is essential for modeling...

Hospital care for children has shifted from general hos...

CHAPEL HILL, NC – Historically, most children in the United States who needed to...

One-stop solution for shaping and outlining objects

Approximately 80% of Apple’s latest iPhone 15 pre-orders in Korea fall within th...

ISSCR opens registration and abstract submission for 20...

Registration and abstracts are open for the ISSCR 2024 Annual Meeting, where aca...

A Google Slides extension can make presentation softwar...

Screen readers, which convert digital text to audio, can make computers more acc...

DGIST develops an artificial intelligence model for eff...

□ Daegu Gyeongbuk Institute of Science and Technology (DGIST), led by President ...

LEO-152020 by Leo Pharma for Atopic Dermatitis (Atopic ...

LEO-152020 is under clinical development by Leo Pharma and currently in Phase II...

Osemitamab by Transcenta for Metastatic Biliary Tract C...

Osemitamab is under clinical development by Transcenta and currently in Phase II...

BGB-10188 by BeiGene for Fallopian Tube Cancer: Likelih...

BGB-10188 is under clinical development by BeiGene and currently in Phase II for...

BGB-10188 by BeiGene for Peritoneal Cancer: Likelihood ...

BGB-10188 is under clinical development by BeiGene and currently in Phase II for...